ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Valencia, VC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near Valencia, VC, ESP:

Adjuvant Palbociclib in Elderly Patients With Breast Cancer (Appalaches)

adjuvant systemic treatment instead of adjuvant chemotherapy followed by endocrine therapy in older patients with stage II-III ER+/HER2- early breast...

Active, not recruiting
Breast Cancer Stage II
Breast Cancer Stage III
Drug: Palbociclib
Drug: Docetaxel / cyclophosphamide

Phase 2

European Organisation for Research and Treatment of Cancer (EORTC)

Valencia, Spain and 72 other locations

in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-low breast cancer with active brain metastases.This study will ana...

Enrolling
Breast Cancer
Metastatic Breast Cancer
Drug: Trastuzumab-Deruxtecan (T-DXd)

Phase 2

MedSIR

Valencia, Spain and 11 other locations

A phase 1b study to assess the combination of ARV-471 and everolimus in participants with advanced or metastatic ER+/HER2- breast cancer...

Active, not recruiting
Breast Cancer
Drug: ARV-471 in combination with Everolimus

Phase 1

Arvinas
Arvinas

Valencia, Spain and 8 other locations

-positive / HER2-negative breast cancer which has spread beyond the original tumor and/or to other organs.During this stud...

Enrolling
Breast Cancer Recurrent
Drug: Standard endocrine therapy
Drug: Palbociclib 125mg

Phase 3

ETOP IBCSG Partners Foundation

Valencia, Spain and 52 other locations

the primary and metastatic (or relapsed) tumor will be collected for central analyses, together with blood, serum and plasma samples. Any s ...

Enrolling
Metastatic Breast Cancer
Procedure: metastatic lesion biopsy
Breast International Group

Valencia, Spain and 51 other locations

participants with metastatic or locally advanced Hormone Receptor (HR) positive and Human Epidermal Growth Factor Receptor (HER)2-negative breast...

Active, not recruiting
Breast Cancer
Locally Advanced Breast Cancer
Drug: Samuraciclib
Drug: Fulvestrant

Phase 2

Carrick Therapeutics

Valencia, Spain and 31 other locations

A Phase 1 Dose Escalation and Expansion Study of AZD9833 Alone or in Combination in Women with ER Positive, HER2 Negative Advanced Breast Ca...

Active, not recruiting
ER+ HER2- Advanced Breast Cancer
Drug: AZD9833 with palbociclib
Drug: AZD9833 with capivasertib

Phase 1

AstraZeneca
AstraZeneca

Valencia, Spain and 16 other locations

number of mutations per coding area of a tumor genome). The HER2-E and Basal-like profiles have been associated with high mutational burden ...

Enrolling
Breast Cancer
Drug: Atezolizumab + Trastuzumab + Vinorelbine

Phase 2

SOLTI

Valencia, Spain and 14 other locations

of T- VEC combined with Atezolizumab in women with operable early breast cancer who present residual disease after Neoadjuvant Chem...

Active, not recruiting
Breast Cancer
Drug: Atezolizumab
Biological: Talimogene laherparepvec

Early Phase 1

SOLTI

Valencia, Spain and 3 other locations

This study to learn more about olaparib and olaparib plus durvalumab combination therapy and also to better understand the studied disease, breast...

Active, not recruiting
Breast Cancer
Combination Product: Neoadjuvant combination therapy with olaparib plus durvalumab
Drug: Neoadjuvant Olaparib monotherapy group

Phase 2

AstraZeneca
AstraZeneca

Valencia, Spain and 43 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems